NCT01168427

Reveal In-Office Implants

Reveal® In-Office Implants Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 66 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to gather evidence about the safety and feasibility of performing the implant procedure for the Reveal Insertable Cardiac Monitor (ICM) in an office or clinic setting rather than the traditional hospital operating room, cardiac catheterization or electrophysiology (EP) laboratory setting.

Conditions

• Arrhythmias, Cardiac

Interventions

Type	Name	Description
DEVICE	Reveal® DX or Reveal® XT Insertable Cardiac Monitor	Reveal® DX and Reveal® XT Insertable Cardiac Monitors are implantable patient-activated and automatically-activated monitoring systems that record subcutaneous ECG.

Timeline

• Start date: 2010-08-01
• Primary completion: 2011-05-01
• Completion: 2011-05-01
• First posted: 2010-07-23
• Last updated: 2018-02-28
• Results posted: 2012-07-26

Locations

9 sites across 1 country: United States